Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8435949 | 0.97 | TSHR (0.37) | LMNATSHRNFKB1CYP1A2MAOA | |
| SCHEMBL8434166 | 0.97 | TSHR (0.37) | LMNATSHRNFKB1CYP1A2MAOA | |
| SCHEMBL9640867 | 0.87 | TSHR (0.30) | LMNATSHRNFKB1CYP1A2MAOA | |
| SCHEMBL2891405 | 0.78 | ACHE (0.35) | LMNATSHRNFKB1CYP1A2MAOA | |
| SCHEMBL6256698 | 0.76 | ALOX15 (0.41) | LMNANFKB1CYP1A2MAOACYP3A4 | |
| SCHEMBL1260075 | 0.71 | — | — | |
| SCHEMBL1744665 | 0.69 | — | — | |
| SCHEMBL8520018 | 0.68 | LMNA (0.36) | LMNACYP1A2CA2BLMPMP22 | |
| SCHEMBL8386040 | 0.67 | — | — | |
| SCHEMBL2034380 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024058984-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2024-03-21 | — | — | WO | disclosed |
| EP-3652133-A1 | MIXTURES COMPRISING AN UREASE INHIBITOR (UI) AND A NITRIFICATION INHIBITOR SUCH AS 2-(3,4-DIMETHYL-1H-PYRAZOL-1-YL)SUCCINIC ACID (DMPSA) OR 3,4-DIMETHYL PYRAZOLIUM GLYCOLATE (DMPG) | BASF SE (DE) | 2020-05-20 | — | — | EP | disclosed |
| WO-2019012382-A1 | MIXTURES COMPRISING AN UREASE INHIBITOR (UI) AND A NITRIFICATION INHIBITOR SUCH AS 2-(3,4-DIMETHYL-1H-PYRAZOL-1-YL)SUCCINIC ACID (DMPSA) OR 3,4-DIMETHYL PYRAZOLIUM GLYCOLATE (DMPG) | BASF SE (DE) | 2019-01-17 | — | — | WO | disclosed |
| EP-1090059-A1 | TERTIARY AMINE POLYAMIDOAMINE-EPIHALOHYDRIN POLYMERS | HERCULES INCORPORATED (US) | 2001-04-11 | — | — | EP | disclosed |
| EP-1062102-A1 | A BOOKBINDING PROCESS | National Starch and Chemical Investment Holding Corporation (US) | 2000-12-27 | — | — | EP | disclosed |
| US-6111032-A | REACTING TERTIARYAMINE POLYAMIDOAMINE PREPOLYMER AND AN EPIHALOHYDRIN WITH A MOLAR RATIO OF EPIHALOHYDRIN AND TERTIARY AMINE OF POLYAMIDOAMINE PREPOLYMER OF LESS THAN 1:1, PH ALKALINE 7.5 TO 9, IN PRESENCE OF NONHALIDE ACID | HERCULES INCORPORATED (US) | 2000-08-29 | — | — | US | disclosed |
| CN-1244801-A | Sulfonylurea-glitazone synergistic combinations for diabetes | WARNER LAMBERT CO (US) | 2000-02-16 | — | — | CN | disclosed |
| WO-1999057175-A1 | TERTIARY AMINE POLYAMIDOAMINE-EPIHALOHYDRIN POLYMERS | HERCULES INCORPORATED (US) | 1999-11-11 | — | — | WO | disclosed |
| WO-1999048698-A1 | A BOOKBINDING PROCESS | NATIONAL STARCH & CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 1999-09-30 | — | — | WO | disclosed |